Abstract:Background Coronary artery calcification (CAC) is common in end-stage renal disease (ESRD) patients, and the extent of CAC is closely related to cardiovascular outcomes in ESRD patients. Cartilage oligomeric matrix protein (COMP), as a component of the vascular matrix, has been found to be an inhibitor of arterial calcification in basic studies. However, there is no clinical research on the correlation between COMP and CAC in maintenance hemodialysis (MHD) patients. The aim of this study was to explore the relationship between serum COMP levels and CAC and cardiovascular events in MHD patients. Methods Serum COMP levels were compared between 54 MHD patients and 66 healthy people. MHD patients were then divided into three groups according to the tertiles of the concentration of COMP level and were followed up for major adverse cardiac events (MACEs), which were defined as a combined end point of new onset angina pectoris, nonfatal myocardial infarction, heart failure, coronary artery revascularization, hospitalization due to angina pectoris and all-cause deaths. The CAC score was calculated based on computed tomography scans. Results The serum COMP level in MHD patients was significantly higher than that in the general population [984.23 (248.43-1902.61) ng/mL vs. 219.01 (97.26-821.92) ng/mL, P < 0.01]. Serum COMP levels were positively correlated with CAC (r = 0.313, P = 0.021) and serum parathyroid hormone in MHD patients (r = 0.359, P < 0.01). Linear regression suggested that after adjusting for age, fasting blood glucose (Glu) and glycosylated hemoglobin (HbAlc), CAC score was an independent predictor in the final model for COMP level (beta = 0.424, t = 3.130, P < 0.01). The receiver operating characteristic (ROC) curve showed that COMP >= 994 mg/mL had 68.0% sensitivity and 72.4% specificity for the prediction of severe CAC [area under the curve (AUC): 0.674, P = 0.030, 95% CI: 0.526-0.882]. After a median follow-up of 16 months (8-24 months), there was no difference in the incidence rate of MACEs between the upper, middle and lower serum COMP groups. Conclusions Our study found that MHD patients have higher levels of circulating COMP than controls. The serum COMP level is positively correlated with CAC score and could be used as a biomarker of severe CAC in MHD patients. However, there is no obvious correlation between serum COMP levels and the incidence of cardiovascular events.

Between bone sialoprotein and abdominal aortic calcification in maintenance hemodialysis patients

Circulating bone-specific alkaline phosphatase and abdominal aortic calcification in maintenance hemodialysis patients.

Incidence of abdominal aortic calcification and its relationship with cardiovascular diseases in patients undergoing maintenance hemodialysis

Association of abdominal aortic calcification estimated by plain radiography with outcomes in haemodialysis patients: A 6-year follow-up study

Abdominal aortic calcification detected by lateral lumbar X-ray in maintenance hemodialysis patients

Relationship of Abdominal Aortic Calcification with Lumbar Vertebral Volumetric Bone Mineral Density Assessed by Quantitative Computed Tomography in Maintenance Hemodialysis Patients

Abdominal Aortic Calcification Score Can Predict All-Cause and Cardiovascular Mortality in Maintenance Hemodialysis Patients.

Serum soluble Klotho level is associated with abdominal aortic calcification in patients on maintenance hemodialysis

Association of plasma microRNA-16-5p and abdominal aortic calcification in maintenance hemodialysis patients

Association of Serum Sclerostin Level with Mineral Disorder and Bone Density in Patients on Maintenance Hemodialysis

P1258CLINICAL COMPARATIVE STUDY OF AORTIC ARCH CALCIFICATION IN PATIENTS WITH MAINTENANCE PERITONEAL DIALYSIS AND HEMODIALYSIS

Correlation between circulating dephosphorylated uncarboxylated matrix Gla protein and vascular calcification in peritoneal dialysis patients

The predictive value of serum galectin 3 for abdominal aortic calcification in maintenance hemodialysis patients: A prospective cohort study

Interrelations among Vascular Calcification, Bone Density, Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor Kb Ligand in Hemodialysis Patients

Abdominal Aortic Calcification Can Predict All-Cause Mortality And Cv Events In Dialysis Patients: A Systematic Review And Meta-Analysis

Correlation factors of aortic arch calcification in 220 maintenance hemodialysis patients

Association Between Serum Cartilage Oligomeric Matrix Protein and Coronary Artery Calcification in Maintenance Hemodialysis Patients

Association of Serum Phosphorus Variability with Coronary Artery Calcification among Hemodialysis Patients

Association of Serum FGF23 with Abdominal Aortic Calcification and Outcomes in Maintenance Hemodialysis Patients

Aortic Artery and Cardiac Valve Calcification Are Associated with Mortality in Chinese Hemodialysis Patients: A 3.5 Years Follow-up.

Effect of Serum FGF‐23, MGP and Fetuin‐a on Calcium‐phosphate Metabolism in Maintenance Hemodialysis Patients